Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
D1.74 - Molecular IgE sensitization profiling in a patient with Asteraceae weed pollen allergy and anaphylaxis to honey
D1.75 - Anaphylaxis during Picc Line replacement
D1.76 - The Hot Chocolate Drink Dilemma
D1.77 - Perioperative Hypersensitivity Outcomes: A retrospective review of 112 patients seen between 2019 and 2024 at two allergy centres
D1.78 - Analytical Verification of Omega-5 gliadin (Tri a 19) Allergen Assay on the IMMULITE 2000 XPi System*
D1.79 - Cardiovascular symptoms during anaphylaxis: An analysis from the European Anaphylaxis Registry
D1.82 - Diagnostic challenges in amoxicillin-clavulanate anaphylaxis: an inconclusive in vitro study – Case Report
D1.83 - Asthma and multi-food allergy were risk factors for Oral Food Challenge failure
D1.84 - IgE-mediated allergy to chlorhexidine: case report
D1.85 - Basophil activation test in β-Lactam Anaphylaxis: A Case Series from a Tertiary Hospital
D1.86 - Hypersensitivity Reaction to Lugol’s Solution: A Case Report
D2.150 - Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom
D2.159 - Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers
D2.149 - EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY
D2.151 - Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)
D2.152 - Study design for the effect of SCIT on tic symptoms in Children and Adolescents with HDM aLlergy and coMorbid tic disorders: a multicenter prospective observational study (CALM study)
D2.153 - Allergenicity and Immunogenicity of Polypeptide-Conjugated Hepatitis B Core Antigen Virus‐Like-Particle (HBcAg-VLP) Vaccine for Treatment of Shellfish Allergy
D2.154 - Real-life observational study on the effectiveness of a broad-spectrum allergen product in unresponsive pediatric patients
D2.155 - Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy
D2.156 - Study on the Effect of the Mucosal Vaccine MV130 on Innate Immunity Factors in School-Age Children
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download